目录
- Chinese guidelines for diagnosis and treatment of primary lung cancer 2018 (English version)
- Chinese guidelines for diagnosis and treatment of renal cell carcinoma 2018 (English version)
- Chinese guidelines for diagnosis and treatment of urothelial carcinoma of bladder 2018 (English version)
- Chinese guidelines for diagnosis and treatment of prostate cancer 2018 (English version)
- Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for head and neck cancer 2018(English version)
- Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for persistent/recurrent and metastatic differentiated thyroid cancer 2018 (English version)
- Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer 2018(English version)
- Incidence and mortality of primary bone cancers in China, 2014
- Incidence and mortality of thyroid cancer in China, 2008-2012
- Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary sites of origin: Analysis of 1,085 WHO classified cases in a single institution in China
- Prognostic value of 18F-fluorodeoxyglucose positron emission tomography using Deauville criteria in diffuse large B cell lymphoma treated with autologous hematopoietic stem cell transplantation
- Metastatic patterns and surgical methods for lymph nodes No. 5 and No. 6 in proximal gastric cancer
- Risk-stratification model to select conversion surgery for advanced gastric cancer patients
- Prognostic implications of epidermal growth factor receptor variant III expression and nuclear translocation in Chinese human gliomas
- STIM1 expression is associated with osteosarcoma cell survival
- Colorectal cancer, radiotherapy and gut microbiota